LYC had a protective role in a rat model of NAFLD by lowering liver enzyme levels, such as AST, ALT, ALP, and albumin, and lipid metabolites such as TG, cholesterol, HDL, LDL, and VLDL [34,35,36,37,38]. Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.